Bloomberg Pfizer Inc is in advanced talks to buy Global Blood Therapeutics Inc., the maker of a therapy for sickle-cell disease, for about $5 billion, the Wall Street Journal (WSJ) reported. The New York-based drug giant is looking to finalise a deal in the coming days, the Journal reported. Bloomberg News had reported earlier this week that biotech was ...

  Bloomberg As volcanic activity in Iceland starts, the country’s tourism industry kicked into high gear, grasping an opportunity to revive the business after the pandemic had banished most visitors from the Atlantic island for more than two years. With reports emerging of sightings of lava, the shares of Icelandic airlines Icelandair hf and Fly Play hf, which flies under ...

  Bloomberg Italy’s sovereign rating outlook was lowered to negative by Moody’s Investors Service, which cited accumulated risks from Russia’s war in Ukraine to departure of PM Mario Draghi. Italy’s finance ministry called action “questionable.” The credit quality of the European nation, which is rated Baa3 by Moody’s, is under pressure from heightened government risk that could impede structural reforms, ...